Garg Himanshu, Douglas Maggie, Turkington Gordon Douglas, Turkington Douglas
Adult Services, Bradford District Care NHS Foundation Trust, Bradford, UK.
Wolfson Research Centre, CNTW, Newcastle upon Tyne, UK.
BMJ Case Rep. 2021 Mar 22;14(3):e240283. doi: 10.1136/bcr-2020-240283.
Many patients with chronic fatigue syndrome (CFS) fail to derive benefit from evidence-based treatments such as cognitive-behavioural therapy (CBT) and graded exercise therapy leading to permanent disability. To discover whether a repeat prescription of modafinil might potentiate the benefits of CBT leading to social recovery as defined by 2 or more point improvement in energy and muscular pain/concentration and return to work or full-time training. Three patients with treatment-resistant CFS (mean duration 17.66 years) treated with modafinil and CBT in a Liaison Psychiatry clinic were retrospectively reviewed. Progress was reviewed at baseline, 4-6 months and 10-24 months. Patients rated their fatigue, pain and concentration using 10-point Likert scales. 2/3 achieved clinically meaningful improvements in energy and pain/concentration and 3/3 achieved social recovery. Modafinil, when prescribed over the medium term, would appear to be a potentially useful potentiating agent when added to CBT.
许多慢性疲劳综合征(CFS)患者无法从认知行为疗法(CBT)和分级运动疗法等循证治疗中获益,最终导致永久性残疾。为了探究重复开具莫达非尼处方是否可能增强CBT的疗效,从而实现社会康复,即精力、肌肉疼痛/注意力改善2分或更多分,并恢复工作或全职训练。对在联络精神科诊所接受莫达非尼和CBT治疗的3例难治性CFS患者(平均病程17.66年)进行了回顾性研究。在基线、4 - 6个月和10 - 24个月时评估进展情况。患者使用10分制李克特量表对疲劳、疼痛和注意力进行评分。2/3的患者在精力和疼痛/注意力方面取得了具有临床意义的改善,3/3的患者实现了社会康复。从中期来看,莫达非尼添加到CBT中时似乎是一种潜在有用的增效剂。